Journey Medical Corp (DERM) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Journey Medical Corp (DERM:NASDAQ), powered by AI.

Current Price
$6.11
Sector
Healthcare
What is the Journey Medical Corp stock price forecast?

Journey Medical Corp is currently trading at $6.11. View real-time AI analysis on Alpha Lenz.

What is Journey Medical Corp insider trading activity?

View the latest insider trading data for Journey Medical Corp on Alpha Lenz.

What is Journey Medical Corp's P/E ratio?

View Journey Medical Corp's valuation metrics on Alpha Lenz.

Journey Medical Corp

NASDAQ · DERM
$6.11-0.23(-3.63%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Journey Medical Corp's future dividend policy...
Alpha Chat Insight

Journey Medical Corp's ROE is -44.0%. Explore profitability and growth together.

Ask for details

Company Overview

Journey Medical Corp is an esteemed biopharmaceutical company focused on the dermatological sector. Its primary function is to develop and commercialize innovative pharmaceutical products that address the unmet medical needs in dermatology. Journey Medical Corp's portfolio includes a wide range of dermatological products designed to treat various conditions, including acne, rosacea, and other skin disorders. The company's emphasis on dermatology allows it to significantly impact the healthcare industry by providing critical treatments that enhance patient care and outcomes. As a player in the biopharmaceutical market, Journey Medical Corp contributes to advancing medical research and development, particularly in skin care solutions. This focus not only enhances its importance in the healthcare sector but also emphasizes the growing need for specialized therapies in dermatology, underscoring its role in improving the quality of life for patients suffering from chronic skin conditions.

CEOMr. Claude Maraoui
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees41

Company Statistics

FY 2025

Profile

N/AMarket Cap
$61.86MRevenue
0.00Shares Out
41Employees

Margins

66.17%Gross
-5.23%EBITDA
-13.21%Operating
-18.38%Pre-Tax
-18.48%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-5.66%Rev 3Yr
6.79%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-13.08%ROA
-44.03%ROE
-8.78%ROIC

Financial Health

$24.09MCash & Cash Equivalents
$38.65MNet Debt
196.96%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Journey Medical Corp (ticker: DERM) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 41 employees.

The current price is $6.11 with a P/E ratio of -x and P/B of -x.

ROE is -44.03% and operating margin is -13.21%. Annual revenue is $62M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Journey Medical Corp (DERM) Stock Forecast 2026 $6.11 — Price, Financials & Analyst Targets | Alpha Lenz